Study #2024-1129
Safety, tolerability, pharmacokinetics, and preliminary efficacy of BTX-9341 in participants with advanced and/or metastatic breast cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Rachel Layman
Department:
Breast Medical Oncology
For general questions about clinical trials:
1-833-749-2612
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.